Associated Papers
Blau syndrome with hypertension and hepatic granulomas: a case report and literature review.
Yao F et al.
Frontiers in Pediatrics, 2023
Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation.
Zhou L et al.
Cell Death and Differentiation, 2022
Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L et al.
Frontiers in Immunology, 2022
Blau syndrome following a bacterial infection.
Sidiqi A et al.
Journal of Aapos : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus, 2020
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.
Raaijmakers MI et al.
Oncotarget, 2016
27791198 (PubMed )
Supplement: oncotarget-07-77163-s002.xlsx › M121224
Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.
Parkhouse R et al.
Febs Letters, 2014
Cardiac infiltration in early-onset sarcoidosis associated with a novel heterozygous mutation, G481D, in CARD15.
Okada S et al.
Rheumatology (oxford, England), 2009
Select a paper to view details